Location History:
- North Potomac, CT (US) (2015)
- North Potomac, MD (US) (2016 - 2017)
Company Filing History:
Years Active: 2015-2017
Title: Min He: Innovator in Cytotoxic Spliceostatin Analog Development
Introduction
Min He is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of cytotoxic spliceostatin analogs. With a total of 3 patents to his name, his work is paving the way for innovative treatments in cancer therapy.
Latest Patents
Min He's latest patents focus on spliceostatin analogs and methods for their preparation. The present invention is directed to novel cytotoxic spliceostatin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer. This groundbreaking work has the potential to significantly impact cancer treatment protocols.
Career Highlights
Min He is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves extensive research and development in the field of oncology, where he applies his expertise to create effective therapeutic solutions.
Collaborations
Throughout his career, Min He has collaborated with esteemed colleagues such as Chakrapani Subramanyam and Frank Erich Koehn. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new medical treatments.
Conclusion
Min He is a distinguished inventor whose work in cytotoxic spliceostatin analogs is making strides in cancer treatment. His contributions to Pfizer Corporation and collaborations with other experts highlight his commitment to advancing medical science.